China emerges victorious in the face of global shortage of COVID vaccines

China emerges victorious in the face of global shortage of COVID vaccines


Coronavirus numbers in India and the world are not looking good. More than 126,000 infections have been registered in India in the past 24 hours. Worldwide, more than 500,000 people tested positive every day for the past seven days. This is an average number. Brazil and India are the new hotspots. Two factors cause an increase in infections. On the one hand, the virus variants. Second: massive global shortage of vaccines. China is a winner in this situation.

Read more on China emerges victorious in the face of global shortage of COVID vaccines…


Coronavirus numbers in India and the world are not looking good. More than 126,000 infections have been registered in India in the past 24 hours. Worldwide, more than 500,000 people tested positive every day for the past seven days. This is an average number. Brazil and India are the new hotspots. Two factors cause an increase in infections. On the one hand, the virus variants. Second: massive global shortage of vaccines. China is a winner in this situation.

As the vaccine shortages make countries desperate, they are buying China’s unproven vaccines by the millions. Like overnight, China has become the largest manufacturer and exporter of Wuhan virus vaccines.

Coronavirus is no longer the same. It mutates and takes many forms. Some of these variants are more contagious. The Wuhan virus had mutated more than 12,000 times by November 2020. Most of these mutations are normal, but some are serious. Experts are tracking four of them.

The first is called the Brazil variant. Scientists call this “P1”. It was first identified in the Amazonian city of Manaus in December 2020. Now it is the dominant variety in Brazil. There’s no evidence that this variant makes a patient uncomfortable, but it spreads faster.

As of Thursday (April 8), Brazil recorded more than four thousand deaths from the Wuhan virus in a single day.

The next variant is the UK variant. Scientists call it “B1.1.7”. It was first discovered in the UK last September. At this point it was only seen in 1 in 4 patients.

By December, nearly two-thirds of new cases in London had been affected by this burden.

Countries have started imposing travel bans on the UK. That didn’t stop the spread. Now the variant can be found on all major continents. Then we have the South African variant.

This has also spread to a number of countries. Experts believe vaccines against the South African strain are less effective. And the fourth is called “double mutant”.

This variant was recently found in India in samples from Maharastra, Delhi, and Punjab. This virus is called a double mutant because the variant carries two mutations

This allows the virus to evade the body’s immune system. It could be resistant to antibodies.

Even those who have recovered could contract the Wuhan virus again. This could also mean weaker immunity to existing vaccines.

So there are four serious mutations in the virus. And all four types were found in India.

Is that why the falls are skyrocketing? It cannot be said for sure.

That’s because Indian authorities are reportedly not testing enough for newer strains. India tested fewer than one percent of its positive samples for variants, according to a report.

By comparison, the UK has sequenced eight percent of the infections. And 33 percent in the past week. So we just don’t know how the new varieties will behave in India.

So far, the experts have claimed that the vaccine will work against the new strains. But there aren’t enough vaccines.

The EU has decided to curb vaccine exports for six weeks.

Australian Prime Minister Scott Morrison yesterday complained about supply shortages in Europe.

In America there is a shortage of Johnson and Johnson shot. Several cities are preparing for a supply disruption.

Same goes for the UK. It has now started using the Moderna vaccine. That’s because the rollout of other recordings has dropped to its lowest point this year. There is a supply crisis at Astrazeneca.

It was caused by manufacturing issues in the company.

Astrazeneca had signed a contract with the Indian Serum Institute to manufacture the Oxford vaccine

AstraZeneca therefore relied on the Serum Institute for the supply. Now it has sent a legal notice to its Indian partner. AstraZeneca blames the Serum Institute for delivery delays. Some Indian states also complain of delivery delays.

They say the Astrazeneca vaccine or Covishield are not available in sufficient quantities. It is one of the two vaccines that have been proven for use in India. The Indian government has already temporarily suspended all exports of the vaccine. Complaints about bottlenecks in India are unfounded. The Indian Minister of Health shared these figures.

He says there are enough vaccines to get around India. For the rest of the world, however, the shortage is serious.

China knows the governments are desperate. You will be taking vaccines even if effectiveness is questionable.

And that’s exactly what hpening is. According to reports, 70 countries and territories have either proven Chinese gunfire or reached agreements to secure them.

Beijing even donated shots to 37 countries. China has produced 230 million cans. By March, it had exported more than 100 million shots. By comparison, India has exported 63 million cans to 84 countries.

And the European Union has exported 58 million cans. What about the rest of the developed world?

They don’t believe in sharing. They are busy vaccinating their own citizens first.

The result is that China is leading the export of Wuhan virus vaccines with unproven shots.

.

COMMENTS